Clinical Heterogeneity of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked: Pulmonary Involvement as a Non-Classical Disease Manifestation

Journal of Clinical Immunology

Volumn 34, Issue 6, 2014, Pages 601-606

  Baris, Safa ^a,i   Schulze, Ilka ^b   Ozen, Ahmet ^a   Aydiner, Elif Karakoc ^a   Altuncu, Emel ^c   Karasu, Gulsun Tezcan ^d   Ozturk, Nilufer ^e   Lorenz, Myriam ^f   Schwarz, Klaus ^b,f,g   Vraetz, Thomas ^h   Ehl, Stephan ^b,h   Barlan, Isil B ^a  

^a Division of Pediatric Allergy and Immunology   (Turkey)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Advanced Spine Surgery Center   (Turkey)

^d MEDICAL PARK HOSPITAL   (Turkey)

^e Departments of Anaesthesiology and Intensive Care   (Turkey)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

clinical heterogeneity; FOXP3; IPEX; lung involvement

Indexed keywords

AUTOANTIBODY; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

BLOOD; CASE REPORT; CHILD; FATALITY; GENETIC DISEASES, X-LINKED; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFANT; LYMPHOCYTE SUBPOPULATION; MALE; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; PEDIGREE; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; RESPIRATORY DISTRESS SYNDROME, ADULT; TURKEY;

AGE OF ONSET; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNE TOLERANCE; INFANT; LYMPHOCYTE SUBSETS; MALE; MUTATION; PEDIGREE; RESPIRATORY DISTRESS SYNDROME, ADULT; T-LYMPHOCYTES, REGULATORY; TURKEY;

EID: 84939879619     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0059-7     Document Type: Article

References (19)

1. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–1.
2. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest. 2000;106:R75–81.
3. Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol. 2008;122:1105–12.
4. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol. 2012;3:211. doi:10.3389/fimmu.2012.00211.
5. An YF, Xu F, Wang M, Zhang ZY, Zhao XD. Clinical and molecular characteristics of immunodys regulation, polyendocrinopathy, enteropathy, X-linked syndrome in China. Scand J Immunol. 2011;74:304–9.
6. d’Hennezel E, Bin Dhuban K, Torgerson T, Piccirillo CA. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2012;49:291–302.
7. Hashimura Y, Nozu K, Kanegane H, et al. Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Nephrol. 2009;24:1181–6.
8. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodys regulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39:537–45.
9. Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders J, et al. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J Allergy Clin Immunol. 2010;126:1000–5.
10. Chi AK, Soubani AO, White AC, Miller KB. An update on pulmonary complications of hematopoietic stem cell transplantation. Chest. 2013;144:1913–22.
11. Sharma R, Jarjour WN, Zheng L, Gaskin F, Fu SM, Ju ST. Large functional repertoire of regulatory T-cell suppressible autoimmune T-cells in scurfy mice. J Autoimm. 2007;29:10–9.
12. Torgerson TR, Linane A, Moes N, Anover S, Mateo V, Rieux-Laucat F, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology. 2007;132:1705–17.
13. Moes N, Rieux-Laucat F, Begue B, Verdier J, Neven B, Patey N, et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology. 2010;139:770–8.
14. d’Hennezel E, Ben-Shoshan M, Ochs HD, Torgerson TR, Russell LJ, Lejtenyi C, et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med. 2009;361:1710–3.
15. McMurchy AN, Gillies J, Allan SE, Passerini L, Gambineri E, Roncarolo MG, et al. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells. J Allergy Clin Immunol. 2010;126:1242–51.
16. Li B, Samanta A, Song X, Iacono KT, Brennan P, Chatila TA, et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol. 2007;19:825–35.
17. Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest. 2006;116:1713–22.
18. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature. 2007;445:936–40.
19. Katoh H, Qin ZS, Liu R, Wang L, Li W, Li X, et al. FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1. Mol Cell. 2011;44:770–84.